<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">Systemic diseases</z:e> affecting the lung are fortunately relatively rare in paediatric practice </plain></SENT>
<SENT sid="1" pm="."><plain>A number of conditions do, however, cause significant respiratory complications, which can result in serious morbidity and mortality in this age group </plain></SENT>
<SENT sid="2" pm="."><plain>These include <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorders</z:e> such as <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, <z:e sem="disease" ids="C0011633" disease_type="Disease or Syndrome" abbrv="">dermatomyositis</z:e> and <z:hpo ids='HP_0100324'>scleroderma</z:hpo>, inherited <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorders</z:e> such as <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehlers-Danlos</z:e> and <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e>, <z:e sem="disease" ids="C0085078" disease_type="Disease or Syndrome" abbrv="">lysosomal storage disorders</z:e> such as <z:e sem="disease" ids="C0026703" disease_type="Disease or Syndrome" abbrv="">mucopolysaccharidoses</z:e>, familial <z:hpo ids='HP_0002459'>dysautonomia</z:hpo>, Langerhans cell histocytosis, pulmonary <z:e sem="disease" ids="C0334102" disease_type="Disease or Syndrome" abbrv="">lymphangiomatosis</z:e>, <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> and <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The investigations of these conditions are often complex but form part of the overall multisystem review of each individual patient </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment is individualised but often requires the extended use of <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and other <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>The outcome is variable and depends on the ability to control the underlying condition </plain></SENT>
<SENT sid="6" pm="."><plain>Long-term <z:hpo ids='HP_0011010'>chronic</z:hpo> lung damage is not unusual and these diseases, when they affect the lung, carry a small but significant mortality </plain></SENT>
</text></document>